Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action
- 1 April 2021
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 329, 205-207
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
- Eli Lilly and Company
- Novartis
This publication has 23 references indexed in Scilit:
- Improving health literacy in patients with chronic conditions: A call to actionInternational Journal of Cardiology, 2018
- Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factorsInternational Journal of Cardiology, 2018
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2018
- Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)BMJ Open Diabetes Research & Care, 2016
- Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient dataThe Lancet Diabetes & Endocrinology, 2016
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004American Heart Journal, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- The Challenge of Achieving National Cholesterol Goals in Patients With DiabetesDiabetes Care, 2005